Cencora Inc to Release Quarterly Results on August 6, 2025
Cencora Inc, a pharmaceutical company, will release its latest quarterly results on August 6, 2025.
Earnings Per Share and Revenue Expectations
Analysts expect a 59% increase in earnings per share compared to the previous year. Revenue is also expected to grow, with a 7.88% increase from the previous quarter.
Fiscal Year Projections
For the fiscal year, analysts predict a substantial increase in earnings per share and revenue.
Stock Price Performance
The company’s stock price has been trending upwards, with a recent 52-week high of $309.35.
Potential Impact of Board Appointment
The appointment of Leslie Donato, a former Cencora executive, to the board of directors of Mallinckrodt plc may have a positive impact on Cencora’s future prospects.
Key Statistics
- Expected earnings per share increase: 59%
- Expected revenue increase from previous quarter: 7.88%
- Recent 52-week high stock price: $309.35